Putnam Investments’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
$98M Buy
624,978
+2,128
+0.3% +$326K 0.13% 125
2023
Q3
$97M Sell
622,850
-172,890
-22% -$28.5M 0.15% 113
2023
Q2
$132M Sell
795,740
-45,993
-5% -$7.42M 0.19% 111
2023
Q1
$130M Sell
841,733
-1,425
-0.2% -$230K 0.21% 110
2022
Q4
$149M Sell
843,158
-53,311
-6% -$9.2M 0.26% 100
2022
Q3
$146M Sell
896,469
-3,061,820
-77% -$518M 0.28% 95
2022
Q2
$703M Sell
3,958,289
-5,799
-0.1% -$1.03M 1.26% 14
2022
Q1
$703M Buy
3,964,088
+45,730
+1% +$7.78M 1.06% 20
2021
Q4
$670M Sell
3,918,358
-100,182
-2% -$16.4M 0.96% 21
2021
Q3
$649M Sell
4,018,540
-16,202
-0.4% -$2.76M 1.01% 18
2021
Q2
$665M Buy
4,034,742
+4,070
+0.1% +$674K 1.03% 20
2021
Q1
$662M Sell
4,030,672
-47,328
-1% -$7.66M 1.1% 17
2020
Q4
$642M Buy
4,078,000
+73,947
+2% +$10.9M 1.14% 17
2020
Q3
$596M Buy
4,004,053
+10,200
+0.3% +$1.51M 1.17% 18
2020
Q2
$562M Buy
3,993,853
+97,267
+2% +$14.2M 1.19% 16
2020
Q1
$511M Sell
3,896,586
-111,937
-3% -$15.9M 1.34% 14
2019
Q4
$585M Buy
4,008,523
+164,944
+4% +$22.4M 1.2% 14
2019
Q3
$497M Buy
3,843,579
+25,218
+0.7% +$3.32M 1.11% 16
2019
Q2
$532M Sell
3,818,361
-51,848
-1% -$7.18M 1.18% 12
2019
Q1
$541M Buy
3,870,209
+347,318
+10% +$46.5M 1.26% 13
2018
Q4
$455M Buy
3,522,891
+28,553
+0.8% +$3.98M 1.2% 13
2018
Q3
$483M Sell
3,494,338
-34,491
-1% -$4.58M 1.04% 15
2018
Q2
$428M Sell
3,528,829
-145,990
-4% -$18.2M 0.97% 16
2018
Q1
$471M Sell
3,674,819
-282,674
-7% -$38.2M 1.1% 16
2017
Q4
$553M Sell
3,957,493
-348,130
-8% -$48.5M 1.23% 16
2017
Q3
$560M Sell
4,305,623
-214,247
-5% -$28.4M 1.29% 15
2017
Q2
$598M Buy
4,519,870
+130,183
+3% +$16.6M 1.4% 12
2017
Q1
$547M Buy
4,389,687
+285,818
+7% +$34.1M 1.28% 11
2016
Q4
$473M Sell
4,103,869
-69,434
-2% -$8.02M 1.14% 12
2016
Q3
$493M Sell
4,173,303
-106,287
-2% -$12.9M 1.19% 13
2016
Q2
$519M Buy
4,279,590
+892,686
+26% +$101M 1.26% 9
2016
Q1
$366M Sell
3,386,904
-260,795
-7% -$27M 0.87% 19
2015
Q4
$375M Buy
3,647,699
+12,622
+0.3% +$1.27M 0.85% 26
2015
Q3
$339M Sell
3,635,077
-167,985
-4% -$16.3M 0.76% 25
2015
Q2
$371M Sell
3,803,062
-215,949
-5% -$21.6M 0.74% 26
2015
Q1
$404M Buy
4,019,011
+34,106
+0.9% +$3.47M 0.81% 22
2014
Q4
$417M Sell
3,984,905
-130,515
-3% -$13.8M 0.86% 19
2014
Q3
$439M Sell
4,115,420
-18,288
-0.4% -$1.9M 0.93% 17
2014
Q2
$432M Sell
4,133,708
-208,809
-5% -$21.1M 0.93% 14
2014
Q1
$427M Sell
4,342,517
-509,190
-10% -$47.2M 0.96% 13
2013
Q4
$444M Buy
4,851,707
+629,678
+15% +$58M 1.07% 8
2013
Q3
$366M Sell
4,222,029
-492,944
-10% -$44.2M 0.98% 9
2013
Q2
$405M Buy
+4,714,973
New +$400M 1.18% 7

Other funds holding JNJ

Putnam Investments's JNJ Position: Q4 2023 in Review

Putnam Investments increased its Johnson & Johnson (JNJ) stake by 0.34% in Q4 2023, buying an estimated $326K and bringing the position to 624,978 shares worth $98M. The position accounts for 0.13% of the portfolio, ranked #125.

Putnam Investments first reported a position in JNJ in Q2 2013 and has held it in 43 quarters since. The position peaked at $703M in Q2 2022. 3,868 funds tracked by Wall St. Rank hold JNJ as of Q4 2023.

  • Putnam Investments held 624,978 shares of Johnson & Johnson worth $98M as of Q4 2023.
  • Putnam Investments bought 2,128 Johnson & Johnson shares in Q4 2023, an estimated $326K.
  • Johnson & Johnson made up 0.13% of Putnam Investments's portfolio in Q4 2023, its #125 holding.
  • Putnam Investments first reported a position in Johnson & Johnson in Q2 2013 and has held it in 43 quarters since.
  • Putnam Investments's Johnson & Johnson position peaked at $703M in Q2 2022.
  • 3,868 funds tracked by Wall St. Rank held Johnson & Johnson as of Q4 2023.

Based on Putnam Investments's 13F filing for Q4 2023, filed 14 Feb 2024.